XPhyto Therapeutics Corp.: XPhyto Announces Head of Sales, E

VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / January 17, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of

Related Keywords

Germany , United States , Canada , Uttenweiler , Baden Wüberg , Vancouver , British Columbia , America , German , Canadian , Drahoslav Zdarek , Hugh Rogers , Knox Henderson , Pharma Gmb , Heinrich Jehle , Roland Spleiss , Thomas Beckert , Teva Pharmaceutical , Company German Ce Mark , Head Of Diagnostic Research , Xphyto Therapeutics Corp , Company Head Of Sales , European Union , Business Development , Head Of Business Development , Cell Pharma Gmbh , Stada Arzneimittel , North America , Market Regulator , Xphyto , Herapeutics , Orp , Nnounces , Head , Sales , Europe ,